ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-26V10321
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gamma aminobutyric Acid GABA Receptor Agonist Market Research Report 2022
BUY CHAPTERS

Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Research Report 2025

Code: QYRE-Auto-26V10321
Report
March 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries
Novartis
Aytu Bioscience
Dr. Reddy’s Laboratories
Endo Pharmaceuticals
Lupin Ltd
Johnson & Johnson Services
Lannett
Sun Pharmaceutical Industries
Cipla Ltd
Aurobindo Pharma
Zydus Cadila

Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size

The global market for Gamma-aminobutyric Acid (GABA) Receptor Agonist was valued at US$ 190 million in the year 2024 and is projected to reach a revised size of US$ 277 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Gamma-aminobutyric Acid (GABA) Receptor Agonist Market

Gamma-aminobutyric Acid (GABA) Receptor Agonist Market

Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.
Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.
This report aims to provide a comprehensive presentation of the global market for Gamma-aminobutyric Acid (GABA) Receptor Agonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gamma-aminobutyric Acid (GABA) Receptor Agonist.
The Gamma-aminobutyric Acid (GABA) Receptor Agonist market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gamma-aminobutyric Acid (GABA) Receptor Agonist companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Report

Report Metric Details
Report Name Gamma-aminobutyric Acid (GABA) Receptor Agonist Market
Accounted market size in year US$ 190 million
Forecasted market size in 2031 US$ 277 million
CAGR 5.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Mylan N.V., Teva Pharmaceutical Industries, Novartis, Aytu BioScience, Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Lupin, Johnson & Johnson Services, Lannett, Sun Pharmaceutical Industries, Cipla, Aurobindo Pharma, Zydus Cadila
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gamma-aminobutyric Acid (GABA) Receptor Agonist company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gamma-aminobutyric Acid (GABA) Receptor Agonist Market growing?

Ans: The Gamma-aminobutyric Acid (GABA) Receptor Agonist Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Gamma-aminobutyric Acid (GABA) Receptor Agonist Market size in 2031?

Ans: The Gamma-aminobutyric Acid (GABA) Receptor Agonist Market size in 2031 will be US$ 277 million.

Who are the main players in the Gamma-aminobutyric Acid (GABA) Receptor Agonist Market report?

Ans: The main players in the Gamma-aminobutyric Acid (GABA) Receptor Agonist Market are Sanofi, Mylan N.V., Teva Pharmaceutical Industries, Novartis, Aytu BioScience, Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Lupin, Johnson & Johnson Services, Lannett, Sun Pharmaceutical Industries, Cipla, Aurobindo Pharma, Zydus Cadila

What are the Application segmentation covered in the Gamma-aminobutyric Acid (GABA) Receptor Agonist Market report?

Ans: The Applications covered in the Gamma-aminobutyric Acid (GABA) Receptor Agonist Market report are Hospitals, Specialty Clinics, Others

What are the Type segmentation covered in the Gamma-aminobutyric Acid (GABA) Receptor Agonist Market report?

Ans: The Types covered in the Gamma-aminobutyric Acid (GABA) Receptor Agonist Market report are Oral, Parenteral, Intrathecal, Others

Recommended Reports

CNS Therapeutics

Sleep & Sedation

Receptor Modulators

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Parenteral
1.2.4 Intrathecal
1.2.5 Others
1.3 Market by Application
1.3.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Perspective (2020-2031)
2.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Growth Trends by Region
2.2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Historic Market Size by Region (2020-2025)
2.2.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Region (2026-2031)
2.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Dynamics
2.3.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Industry Trends
2.3.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Drivers
2.3.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Challenges
2.3.4 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players by Revenue
3.1.1 Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players by Revenue (2020-2025)
3.1.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Players (2020-2025)
3.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue
3.4 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Concentration Ratio
3.4.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in 2024
3.5 Global Key Players of Gamma-aminobutyric Acid (GABA) Receptor Agonist Head office and Area Served
3.6 Global Key Players of Gamma-aminobutyric Acid (GABA) Receptor Agonist, Product and Application
3.7 Global Key Players of Gamma-aminobutyric Acid (GABA) Receptor Agonist, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gamma-aminobutyric Acid (GABA) Receptor Agonist Breakdown Data by Type
4.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Historic Market Size by Type (2020-2025)
4.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Type (2026-2031)
5 Gamma-aminobutyric Acid (GABA) Receptor Agonist Breakdown Data by Application
5.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Historic Market Size by Application (2020-2025)
5.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2020-2031)
6.2 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2020-2025)
6.4 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2020-2031)
7.2 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2020-2025)
7.4 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2020-2031)
8.2 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2020-2025)
8.4 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2020-2031)
9.2 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2020-2025)
9.4 Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (2020-2031)
10.2 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2020-2025)
10.4 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.1.4 Sanofi Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Mylan N.V.
11.2.1 Mylan N.V. Company Details
11.2.2 Mylan N.V. Business Overview
11.2.3 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.2.4 Mylan N.V. Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.2.5 Mylan N.V. Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Details
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.4.4 Novartis Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Aytu BioScience
11.5.1 Aytu BioScience Company Details
11.5.2 Aytu BioScience Business Overview
11.5.3 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.5.4 Aytu BioScience Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.5.5 Aytu BioScience Recent Development
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Company Details
11.6.2 Dr. Reddy’s Laboratories Business Overview
11.6.3 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.6.4 Dr. Reddy’s Laboratories Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.6.5 Dr. Reddy’s Laboratories Recent Development
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Company Details
11.7.2 Endo Pharmaceuticals Business Overview
11.7.3 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.7.4 Endo Pharmaceuticals Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.7.5 Endo Pharmaceuticals Recent Development
11.8 Lupin
11.8.1 Lupin Company Details
11.8.2 Lupin Business Overview
11.8.3 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.8.4 Lupin Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.8.5 Lupin Recent Development
11.9 Johnson & Johnson Services
11.9.1 Johnson & Johnson Services Company Details
11.9.2 Johnson & Johnson Services Business Overview
11.9.3 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.9.4 Johnson & Johnson Services Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.9.5 Johnson & Johnson Services Recent Development
11.10 Lannett
11.10.1 Lannett Company Details
11.10.2 Lannett Business Overview
11.10.3 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.10.4 Lannett Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.10.5 Lannett Recent Development
11.11 Sun Pharmaceutical Industries
11.11.1 Sun Pharmaceutical Industries Company Details
11.11.2 Sun Pharmaceutical Industries Business Overview
11.11.3 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.11.4 Sun Pharmaceutical Industries Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.11.5 Sun Pharmaceutical Industries Recent Development
11.12 Cipla
11.12.1 Cipla Company Details
11.12.2 Cipla Business Overview
11.12.3 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.12.4 Cipla Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.12.5 Cipla Recent Development
11.13 Aurobindo Pharma
11.13.1 Aurobindo Pharma Company Details
11.13.2 Aurobindo Pharma Business Overview
11.13.3 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.13.4 Aurobindo Pharma Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.13.5 Aurobindo Pharma Recent Development
11.14 Zydus Cadila
11.14.1 Zydus Cadila Company Details
11.14.2 Zydus Cadila Business Overview
11.14.3 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Introduction
11.14.4 Zydus Cadila Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
11.14.5 Zydus Cadila Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries
Novartis
Aytu Bioscience
Dr. Reddy’s Laboratories
Endo Pharmaceuticals
Lupin Ltd
Johnson & Johnson Services
Lannett
Sun Pharmaceutical Industries
Cipla Ltd
Aurobindo Pharma
Zydus Cadila
List of Tables
 Table 1. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oral
 Table 3. Key Players of Parenteral
 Table 4. Key Players of Intrathecal
 Table 5. Key Players of Others
 Table 6. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Region (2020-2025)
 Table 10. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Region (2026-2031)
 Table 12. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Trends
 Table 13. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Drivers
 Table 14. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Challenges
 Table 15. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Restraints
 Table 16. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Players (2020-2025)
 Table 18. Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist as of 2024)
 Table 19. Ranking of Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Gamma-aminobutyric Acid (GABA) Receptor Agonist, Headquarters and Area Served
 Table 22. Global Key Players of Gamma-aminobutyric Acid (GABA) Receptor Agonist, Product and Application
 Table 23. Global Key Players of Gamma-aminobutyric Acid (GABA) Receptor Agonist, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Type (2020-2025)
 Table 27. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Type (2026-2031)
 Table 29. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Application (2020-2025)
 Table 31. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Application (2026-2031)
 Table 33. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Sanofi Company Details
 Table 49. Sanofi Business Overview
 Table 50. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 51. Sanofi Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 52. Sanofi Recent Development
 Table 53. Mylan N.V. Company Details
 Table 54. Mylan N.V. Business Overview
 Table 55. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 56. Mylan N.V. Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 57. Mylan N.V. Recent Development
 Table 58. Teva Pharmaceutical Industries Company Details
 Table 59. Teva Pharmaceutical Industries Business Overview
 Table 60. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 61. Teva Pharmaceutical Industries Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 62. Teva Pharmaceutical Industries Recent Development
 Table 63. Novartis Company Details
 Table 64. Novartis Business Overview
 Table 65. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 66. Novartis Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 67. Novartis Recent Development
 Table 68. Aytu BioScience Company Details
 Table 69. Aytu BioScience Business Overview
 Table 70. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 71. Aytu BioScience Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 72. Aytu BioScience Recent Development
 Table 73. Dr. Reddy’s Laboratories Company Details
 Table 74. Dr. Reddy’s Laboratories Business Overview
 Table 75. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 76. Dr. Reddy’s Laboratories Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 77. Dr. Reddy’s Laboratories Recent Development
 Table 78. Endo Pharmaceuticals Company Details
 Table 79. Endo Pharmaceuticals Business Overview
 Table 80. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 81. Endo Pharmaceuticals Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 82. Endo Pharmaceuticals Recent Development
 Table 83. Lupin Company Details
 Table 84. Lupin Business Overview
 Table 85. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 86. Lupin Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 87. Lupin Recent Development
 Table 88. Johnson & Johnson Services Company Details
 Table 89. Johnson & Johnson Services Business Overview
 Table 90. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 91. Johnson & Johnson Services Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 92. Johnson & Johnson Services Recent Development
 Table 93. Lannett Company Details
 Table 94. Lannett Business Overview
 Table 95. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 96. Lannett Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 97. Lannett Recent Development
 Table 98. Sun Pharmaceutical Industries Company Details
 Table 99. Sun Pharmaceutical Industries Business Overview
 Table 100. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 101. Sun Pharmaceutical Industries Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 102. Sun Pharmaceutical Industries Recent Development
 Table 103. Cipla Company Details
 Table 104. Cipla Business Overview
 Table 105. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 106. Cipla Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 107. Cipla Recent Development
 Table 108. Aurobindo Pharma Company Details
 Table 109. Aurobindo Pharma Business Overview
 Table 110. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 111. Aurobindo Pharma Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 112. Aurobindo Pharma Recent Development
 Table 113. Zydus Cadila Company Details
 Table 114. Zydus Cadila Business Overview
 Table 115. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Product
 Table 116. Zydus Cadila Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025) & (US$ Million)
 Table 117. Zydus Cadila Recent Development
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Gamma-aminobutyric Acid (GABA) Receptor Agonist Picture
 Figure 2. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Type: 2024 VS 2031
 Figure 4. Oral Features
 Figure 5. Parenteral Features
 Figure 6. Intrathecal Features
 Figure 7. Others Features
 Figure 8. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Specialty Clinics Case Studies
 Figure 12. Others Case Studies
 Figure 13. Gamma-aminobutyric Acid (GABA) Receptor Agonist Report Years Considered
 Figure 14. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Region: 2024 VS 2031
 Figure 17. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Players in 2024
 Figure 18. Global Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in 2024
 Figure 20. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Country (2020-2031)
 Figure 22. United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Country (2020-2031)
 Figure 26. Germany Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Region (2020-2031)
 Figure 34. China Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Country (2020-2031)
 Figure 42. Mexico Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Country (2020-2031)
 Figure 46. Turkey Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Sanofi Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 50. Mylan N.V. Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 51. Teva Pharmaceutical Industries Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 52. Novartis Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 53. Aytu BioScience Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 54. Dr. Reddy’s Laboratories Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 55. Endo Pharmaceuticals Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 56. Lupin Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 57. Johnson & Johnson Services Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 58. Lannett Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 59. Sun Pharmaceutical Industries Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 60. Cipla Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 61. Aurobindo Pharma Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 62. Zydus Cadila Revenue Growth Rate in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global γ Aminobutyric Acid Receptor Agonists Market Research Report 2025
Global GABAA Receptor Agonists Market Research Report 2025
Global Gamma Aminobutyric Acid GABA Receptor Market Research Report 2024
Global GABAB Receptor Agonists Market Research Report 2025
Global Novel Benzodiazepine Receptor Agonists Market Research Report 2025
Global GABA Receptor Modulators Market Research Report 2025
Global 4 Aminobutyric Acid Market Insights Forecast to 2030
Global 4 Aminobutanoic Acid Market Insights Forecast to 2030
Global Barbiturate Sedative Drugs Market Research Report 2024
Global Dopamine Receptor Agonists Market Research Report 2025
Global GABA Receptor Agonist Drug Market Research Report 2024
Global γ Aminobutyric Acid Market Research Report 2024
Global Dopamine Receptor Agonists For PD Market Research Report 2025
Opioid Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Baclofen API Market Research Report 2024
Global Clobazam API Market Research Report 2024
Global Long acting Melatonin Receptor Agonists Market Research Report 2025
Global Gamma Aminobutyric Acid GABA Supplement Market Research Report 2024
Global GABA Sleep Gummies Market Research Report 2024
Global Melanocortin Receptor Agonist Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions